Company attributes
Location
B2X
CEO
Founder
Pitchbook URL
Total Funding Amount (USD)
35,000,000
Latest Funding Round Date
November 2020
Latest Funding Type
Country
Other attributes
Company Operating Status
Active
Inipharm is advancing a therapeutic pipeline that addresses severe liver diseases The company's lead program is focused on small-molecules to target the activity of HSD17B13, a target for multiple severe liver and related diseases.
Timeline
No Timeline data yet.
